Evidence map›Paper›PMID 28097158›Full record

ReviewJournal of immunology research2016

Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases.

Nausicaa Clemente, Davide Raineri, Giuseppe Cappellano, Elena Boggio, Francesco Favero, Maria Felicia Soluri, Chiara Dianzani, Cristoforo Comi, Umberto Dianzani, Annalisa Chiocchetti

Open access · goldAbstract readReview
In one paragraph

Review in Journal of immunology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. SPP1BMC medicine · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. ICOSL: more than a trigger of ICOS function.Cell communication and signaling : CCS · 2025
    Review
  8. Osteopontin: Its Properties, Recent Studies, and Potential Applications.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Article
  11. The injury effect of osteopontin in sepsis-associated lung injury.Journal of inflammation (London, England) · 2025
    Article
  12. Review
  13. Article
  14. Multi - dimensional mechanism analysis ofFrontiers in pharmacology · 2025
    Article
  15. Review
  16. Nature communications · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Adipokines and their role in acute pancreatitis.Journal of medical biochemistry · 2024
    Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Nausicaa ClementeDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.ORCID 0000-0002-9860-0148
Davide RaineriDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.
Giuseppe CappellanoBiocenter, Division for Experimental Pathophysiology and Immunology, Laboratory of Autoimmunity, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-5193-4688
Elena BoggioDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.
Francesco FaveroDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.
Maria Felicia SoluriDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.
Chiara DianzaniDepartment of Drug Science and Technology, University of Torino, Torino, Italy.ORCID 0000-0002-2246-3183
Cristoforo ComiDepartment of Translational Medicine, Neurology Unit, "A. Avogadro" UPO, Novara, Italy.ORCID 0000-0002-6862-9468
Umberto DianzaniDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.ORCID 0000-0001-6723-3931
Annalisa ChiocchettiDepartment of Health Sciences and Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), "A. Avogadro" University of Piemonte Orientale (UPO), Novara, Italy.ORCID 0000-0002-4349-1087
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITInnsbruck Medical University · ATUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteopontin (OPN) regulates the immune response at multiple levels. Physiologically, it regulates the host response to infections by driving T helper (Th) polarization and acting on both innate and adaptive immunity; pathologically, it contributes to the development of immune-mediated and inflammatory diseases. In some cases, the mechanisms of these effects have been described, but many aspects of the OPN function remain elusive. This is in part ascribable to the fact that OPN is a complex molecule with several posttranslational modifications and it may act as either an immobilized protein of the extracellular matrix or a soluble cytokine or an intracytoplasmic molecule by binding to a wide variety of molecules including crystals of calcium phosphate, several cell surface receptors, and intracytoplasmic molecules. This review describes the OPN structure, isoforms, and functions and its role in regulating the crosstalk between innate and adaptive immunity in autoimmune diseases.

Indexed as

Adaptive ImmunityAnimalsAutoimmune DiseasesHumansImmunity, InnateMiceOsteopontinProtein Structure, SecondaryProtein Structure, TertiarySignal TransductionOsteopontin

Identifiers

PMID28097158
PMCPMC5206443
OpenAlexW2567315309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.